ArticleBMC gastroenterology2025
Comprehensive age-period-cohort analysis of global pancreatitis burden and socioeconomic disparities (1990-2021).
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Triglyceride-glucose and TyG-BMI indexes predict acute pancreatitis in adult critically ill patients admitted to intensive care.Clinics (Sao Paulo, Brazil) · 2026Article
- Global, regional, and national burden and future projections of pancreatitis: A Joinpoint, APC, and ARIMA modeling analysis.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPancreatitis is a major global health issue, with a rising incidence, intricate management needs, and considerable mortality.This study examines the effects of age, period, birth cohort, and the Socio-demographic Index (SDI) on the burden of pancreatitis in the world and regions' component countries. It also views high alcohol use as a big risk factor.
methodsData were obtained from the 2021 analysis of the Global Burden of Disease (GBD). Pancreatitis incidence, mortality, and Disability-Adjusted Life Years (DALYs) were analyzed by application of the age-period cohort model. Countries were grouped by SDI, and gender-specific trends were explored. Bayesian meta-regression was additionally conducted on the health disparity attributable to high alcohol use.
resultsBetween 1990 and 2021 pancreatitis cases increased globally from 1.73 million (1.50-2.00 million) to 2.75 million (2.41-3.13 million), deaths increased from 68, 490 (60,748-78,272) to 122,416 (109,848-141,362), and DALYs from 2.58 million (2.27- 2.99 million) to 4.10 million (3.65-4.68 million). However, population growth and aging have contributed to a substantial absolute increase in the disease burden. High alcohol use accounted for approximately 16% of global pancreatitis-related deaths, with males bearing a significantly higher proportion of the burden than females. In high and high-middle SDI regions, reductions in ASIR, ASMR, and ASDR reflected the effectiveness of healthcare improvements. Conversely, low and low-middle SDI regions showed rising incidence, mortality, and DALY burdens, reflecting disparities in healthcare resources and preventive measures. Regionally, Eastern Europe reported the highest pancreatitis burden, including DALYs, incidence, and mortality, primarily associated with high alcohol consumption. Conversely, high-income Asia Pacific had the lowest rates on most of these indicators. Age-period-cohort (APC) analysis showed a substantial increase in the burden of pancreatitis occurring in older age groups and recent birth cohorts, especially in low SDI regions. These observations illustrate rising divergences between high and low SDI localities, necessitating the development of prevention and intervention tactics narrowed to the huge and rising inequalities.
conclusionPancreatitis is still a major global health problem with marked disparities between regions. High SDI areas have managed to alleviate the burden through effective political action, but low SDI areas face a growing set. Addressing risk factors such as high alcohol use and providing better healthcare in the low SDI areas are all important. Targeted interventions, better surveillance and greater understanding of the disease are perhaps the areas that future efforts should address.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.